New evidence informs risk factors, diagnosis and care of patients with CVT stroke

American Heart Association Scientific Statement

2024-01-29

(Press-News.org) Embargoed until 4 a.m. CT/5 a.m. ET Monday, Jan. 29, 2024

DALLAS, January 29, 2024 — A new scientific statement from the American Heart Association emphasizes the need to increase patients’ and physicians’ awareness of cerebral venous thrombosis (CVT) to improve the recognition of this condition and initiate prompt medical treatment. The new statement, Diagnosis and Management of Cerebral Venous Thrombosis, published today in the American Heart Association/American Stroke Association’s peer-reviewed journal Stroke. A scientific statement is an expert analysis of current research and may inform future clinical practice guidelines.

This statement reviewed the latest evidence to update the Association’s 2011 statement that outlines recommendations for diagnosing and managing CVT, focusing on advancements in treatment approaches, including anticoagulation (blood thinners), endovascular therapies (procedures using a catheter to reach the blood clot inside the vascular system) and surgery.

Statement Highlights:

Cerebral venous thrombosis (CVT) is a rare type of stroke in which a blood clot forms in the veins that drain blood from the brain. CVT accounts for less than 3% of all strokes, and it often affects younger individuals; women who are pregnant, postpartum or using oral contraceptives; and people with a tendency to form blood clots. Since the previous statement, additional risk factors associated with CVT have been identified: obesity and active COVID-19 infection. The diagnosis of CVT is challenging because the most common symptoms are persistent headaches and seizures, which may mimic other neurological conditions such as migraines or epilepsy. Doctors typically use brain imaging (MRI/CT scans) to identify CVT, however, these tests may not be routinely ordered for patients presenting with headaches or seizures. Recent evidence suggests that vascular imaging of the venous system using new MRI sequences or techniques may improve the likelihood of the diagnosis of CVT. The progression of CVT may be difficult to predict. Although 80-90% of individuals with CVT achieve functional independence, many experience residual symptoms such as headache, fatigue, low mood and impaired cognitive performance. About 10-15% of patients may experience severe outcomes, including death, disability or loss of independence, despite intensive medical treatment. Standard treatment of CVT involves anticoagulation therapy to prevent growth of the blood clot, to facilitate reopening the blood vessel and to prevent recurrent blood clots. Recent studies show the use of direct oral anticoagulants appears to be a safe and effective alternative option to vitamin K antagonists (VKAs), such as warfarin. There is a need to identify other non-invasive treatments that are able to quickly dissolve blood clots and reduce pressure in the veins. Endovascular treatment involves using a catheter to remove the clot and restore blood flow. These procedures are typically reserved for patients with evidence that the blood clot is moving toward the heart, for those with neurological deterioration despite medical therapy or for those who cannot take blood thinners. According to the statement, decompressive craniectomy, or surgical removal of a portion of the skull, is a life-saving procedure to consider for patients with severe CVT or progressive neurological deterioration. Although there are no randomized controlled trials of this surgical approach, a meta-analysis of 51 studies found that surgery within 48 hours of admission may decrease mortality and result in improved functional outcomes in patients with severe or progressive disease. In 2021, the Centers for Disease Control and Prevention (CDC) and the U.S. Food & Drug Administration (FDA) found that adenovirus-based SARS-CoV-2 vaccines were associated with vaccine induced thrombotic thrombocytopenia (VITT), a condition that causes low blood platelet count and affects clotting. Although CVT in VITT is rare, those who develop it have a poor prognosis with a mortality rate of up to 61% , with symptoms such as new onset of headaches typically beginning 5-24 days after vaccination. There is no evidence of VITT in adults who received either the Pfizer or Moderna mRNA COVID-19 vaccines, and the Johnson & Johnson (Janssen) adenovirus-based COVID-19 vaccine was no longer authorized by the FDA as of June 1, 2023. This statement was written by a volunteer writing group on behalf of the American Heart Association’s Stroke Council; the Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation; the Council on Cardiovascular and Stroke Nursing; and the Council on Hypertension. Statement writing group members and their disclosures are listed in the manuscript. American Heart Association scientific statements promote greater awareness about cardiovascular diseases and help facilitate informed health care decisions. Scientific statements outline what is currently known about a topic and what areas need additional research. While scientific statements inform the development of guidelines, they do not make treatment recommendations.

The Association receives funding primarily from individuals. Foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific Association programs and events. The Association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and biotech companies, device manufacturers and health insurance providers, and the Association’s overall financial information are available here.

Additional Resources:

Multimedia is available on the right column of release link. On January 29, access manuscript online here. AHA scientific statement news release: 5 elements to optimize treatment of in-hospital stroke (Feb. 2022) AHA news release: mRNA COVID-19 vaccines preferred; vaccination is #1 protection against serious COVID-19 infection, death (Dec. 2021) AHA news release: Guidance on treatment for rare blood clots and low platelets related to COVID-19 vaccine (April 2021) ASA health information: Heart and Stroke and Statistics ASA health information: About Stroke ASA health information: Types of Stroke and Treatment Follow AHA/ASA news on X (formerly known as Twitter) @HeartNews Follow news from Stroke, the ASA/AHA journal, @StrokeAHA_ASA ###

About the American Heart Association

The American Heart Association is a relentless force for a world of longer, healthier lives. We are dedicated to ensuring equitable health in all communities. Through collaboration with numerous organizations, and powered by millions of volunteers, we fund innovative research, advocate for the public’s health and share lifesaving resources. The Dallas-based organization has been a leading source of health information for a century. During 2024 - our Centennial year - we celebrate our rich 100-year history and accomplishments. As we forge ahead into our second century of bold discovery and impact, our vision is to advance health and hope for everyone, everywhere. Connect with us on heart.org, Facebook, X or by calling 1-800-AHA-USA1.

END

ELSE PRESS RELEASES FROM THIS DATE:

Researchers map genome for cats, dolphins, birds, and dozens of other animals

2024-01-29

Researchers mapped genetic blueprints for 51 species including cats, dolphins, kangaroos, penguins, sharks, and turtles, a discovery that deepens our understanding of evolution and the links between humans and animals. “Being able to access that genetic information will have huge implications for understanding human health and evolution,” said lead author Michael Schatz, a Bloomberg Distinguished Professor of computer science and biology at Johns Hopkins University. “A lot of work ...

Overcoming the stigma: study recommends steps to move past barriers of brain health conversation

2024-01-29

INDIANAPOLIS -- Approximately four of five primary care clinicians consider themselves on the front lines of brain health. In the U.S., clinicians are the first point of contact for patients worried about memory loss and are most likely the first to detect and evaluate patients experiencing mild cognitive impairment, Alzheimer’s disease or related dementias. In a new study focused on understanding the barriers of clinician-patient conversations about brain health and cognitive concerns, Regenstrief Institute and Indiana University School of Medicine Research Scientist Malaz Boustani, M.D., MPH, found that early conversations about brain health between ...

PolyU develops high-efficiency carbon dioxide electroreduction system for reducing carbon footprint and progressing carbon neutrality goals

2024-01-29

Global warming continues to pose a threat to human society and the ecological systems, and carbon dioxide accounts for the largest proportion of the greenhouse gases that dominate climate warming. To combat climate change and move towards the goal of carbon neutrality, researchers from The Hong Kong Polytechnic University (PolyU) have developed a durable, highly selective and energy-efficient carbon dioxide (CO2) electroreduction system that can convert CO2 into ethylene for industrial purposes to provide an effective solution for ...

Lopsided galaxies shed light on the speed of dark matter

2024-01-29

So how can the speed of dark matter be measured? The prerequisite is to find a galaxy in the universe that moves relative to dark matter. Since everything in the universe is in motion and there is a great deal of dark matter, it is not difficult to find such galaxies. Heavy objects, like galaxies, attract all types of matter, whether it is dark matter or visible matter that we encounter on a daily basis. As dark matter moves past a galaxy, the galaxy begins to pull the dark matter particles towards it. However, the change of speed direction of the particles takes time. Before ...

Breast cancer test may make bad chemotherapy recommendations for Black patients

2024-01-29

A common test used to decide whether breast cancer patients should get chemotherapy may be making bad recommendations for some Black women, leading them to forgo chemotherapy when it might have helped, according to new research from the University of Illinois Chicago. The test, known as the 21-gene breast recurrence score, is the most commonly ordered biomarker test used to guide doctor’s recommendations for patients with estrogen receptor-positive breast cancer — the most common ...

First-ever sighting of a live newborn great white

2024-01-29

Great whites, the largest predatory sharks in the world with the most fatal attacks on humans, are tough to imagine as newborn babies. That is partially because no one has seen one in the wild, it seems, until now. Wildlife filmmaker Carlos Gauna and UC Riverside biology doctoral student Phillip Sternes were scanning the waters for sharks on July 9, 2023, near Santa Barbara on California’s central coast. That day, something exciting appeared on the viewfinder of Gauna’s drone camera. It was a shark ...

Back from the dead: Tropical tree fern repurposes its dead leaves

2024-01-29

CHAMPAIGN, Ill. — Plant biologists report that a species of tree fern found only in Panama reanimates its own dead leaf fronds, converting them into root structures that feed the mother plant. The fern, Cyathea rojasiana, reconfigures these “zombie leaves,” reversing the flow of water to draw nutrients back into the plant. Watch a video about the findings. This weird phenomenon occurs only after the leaves die and droop to the ground, said University of Illinois Urbana-Champaign plant biology professor James Dalling, ...

New horizons in chemical biology: A novel approach to synthesize dibenzothiophene s-oxides

2024-01-29

Organic compounds in the field of chemistry range from simple hydrocarbons to complex molecules, with diverse functional groups added to the main carbon backbone. These functional groups impart the compounds distinct chemical properties as well as participate in various chemical transformations, making them important precursors for the synthesis of diverse compounds. Scientists have, therefore, actively engaged in creating molecules that feature novel and highly reactive functional groups. One such class of compounds are dibenzothiophenes and their derivatives containing ...

Variant in the synaptonemal complex protein SYCE2 associates with pregnancy loss through effects on recombination

2024-01-29

A sequence variant that increases risk of pregnancy loss Scientists at deCODE genetics, a subsidiary of Amgen and their collaborators from Iceland, Denmark and USA published a study today in Nature Structural and Molecular Biology titled “Variant in the synaptonemal complex protein SYCE2 associates with pregnancy loss through effects on recombination”. While it is well established that chromosomal abnormalities are a major cause of miscarriages the biology behind pregnancy losses with or without chromosomal errors is not well understood. Over 114 thousand women from Iceland, Denmark, UK, USA and Finland who have ...

How obesity dismantles our mitochondria

2024-01-29

The number of people with obesity has nearly tripled since 1975, resulting in a worldwide epidemic. While lifestyle factors like diet and exercise play a role in the development and progression of obesity, scientists have come to understand that obesity is also associated with intrinsic metabolic abnormalities. Now, researchers from University of California San Diego School of Medicine have shed new light on how obesity affects our mitochondria, the all-important energy-producing structures of our cells. In a study published January ...

New evidence informs risk factors, diagnosis and care of patients with CVT stroke

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: